Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-000917
Filing Date
2023-01-11
Accepted
2023-01-11 21:52:00
Documents
1
Period of Report
2023-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4185
  Complete submission text file 0001437749-23-000917.txt   5628
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2656 CROSSPARK ROAD SUITE 100 CORALVILLE IA 52241
Business Address
Mickle Christal M M (Reporting) CIK: 0001638366 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 23524804